HL-01
AssetAlso Sodium hyaluronate solution - 3.36%
Provides joint viscosupplementation and lubrication using high and low molecular weight sodium hyaluronate.
- Stage
- Phase 3
- Modality
- Other
- Target
- Not known
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Osteo arthritis of the knee
Phase 3, Not yet recruiting, NCT07819461, clinicaltrials.gov, 8 Oct 2026
In the full profile
- Owner and partners1
- Trials1
- Signals2
Every asset’s record: target, stage, trials and the evidence behind it.